Reata Pharmaceuticals, Inc. isamba semali engenayo, imali engenayo yonke kanye nezinguquko zezinguquko eziguqwini US dollar namuhla
Reata Pharmaceuticals, Inc. imali engenayo yamanje kanye nemali engenayo yezikhathi zokubika zakamuva. Imali engenayo Reata Pharmaceuticals, Inc. manje 944 000 $. Imininingwane mayelana nemali engenayo ithathwa emithonjeni evulekile. Imali engenayo, imali engenayo kanye namandla - izinkomba eziphambili zezezimali Reata Pharmaceuticals, Inc.. Isheduli yezezimali ye- Reata Pharmaceuticals, Inc. iqukethe amashadi amathathu ezinkomba zezimali eziphambili zenkampani: impahla ephelele, imali engenayo, imali engenayo. Isheduli yemibiko yezezimali isuka ku- 30/06/2018 kuya ku- 31/03/2021 iyatholakala online. Reata Pharmaceuticals, Inc. imali engenayo ephelele kugrafu iboniswa iphuzi.
|
|
Usuku lokubika
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
futhi
Ushintsho (%)
Ukuqhathaniswa kombiko wesinekota walo nyaka kanye nombiko wekota wonyaka odlule.
|
|
31/03/2021 |
944 000 $ |
-87.782 % ↓ |
-67 455 000 $ |
- |
|
31/12/2020 |
3 192 000 $ |
-59.59 % ↓ |
-65 776 000 $ |
- |
|
30/09/2020 |
1 401 000 $ |
-82.261 % ↓ |
-65 456 000 $ |
- |
|
30/06/2020 |
3 073 000 $ |
-60.668 % ↓ |
-67 581 000 $ |
- |
|
30/09/2019 |
7 898 000 $ |
-
|
-39 694 000 $ |
-
|
|
30/06/2019 |
7 813 000 $ |
-
|
-34 380 000 $ |
-
|
|
31/03/2019 |
7 726 000 $ |
-
|
-29 154 000 $ |
-
|
|
31/12/2018 |
7 899 000 $ |
-
|
-25 583 000 $ |
-
|
|
30/09/2018 |
4 766 000 $ |
-
|
-30 835 000 $ |
-
|
|
30/06/2018 |
7 519 000 $ |
-
|
-28 211 000 $ |
-
|
|
|
Bonisa:
|
|
Ukuze
|
|
|
|
Umbiko wezezimali Reata Pharmaceuticals, Inc., isimiso
Izinsuku zakamuva ze Reata Pharmaceuticals, Inc. ezitholakala online: 30/06/2018, 31/12/2020, 31/03/2021. Izinsuku zezitatimende zezezimali zilawulwa ngokuqinile ngumthetho nezitatimende zezezimali. Usuku lwakamuva lombiko wezezimali we Reata Pharmaceuticals, Inc. yi 31/03/2021. Imali engenayo yokusebenza Reata Pharmaceuticals, Inc. iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo. Imali engenayo yokusebenza Reata Pharmaceuticals, Inc. kuyinto -54 914 000 $
|
|
|
Izinsuku zembiko yezimali Reata Pharmaceuticals, Inc.
Imali engenayo Reata Pharmaceuticals, Inc. iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika. Imali engenayo Reata Pharmaceuticals, Inc. kuyinto -67 455 000 $ Izindleko zokusebenza Reata Pharmaceuticals, Inc. yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi. Izindleko zokusebenza Reata Pharmaceuticals, Inc. kuyinto 55 858 000 $ Imali yamanje Reata Pharmaceuticals, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali yamanje Reata Pharmaceuticals, Inc. kuyinto 777 624 000 $
|
|
Ukulingana Reata Pharmaceuticals, Inc. yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele. Ukulingana Reata Pharmaceuticals, Inc. kuyinto 369 333 000 $
|
|
31/03/2021
|
31/12/2020
|
30/09/2020
|
30/06/2020
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
31/12/2018
|
30/09/2018
|
30/06/2018
|
|
|
Inzuzo enkulu
Inzuzo eyinzuzo yinzuzo eyenziwa yinkampani ngemuva kokunciphisa izindleko zokukhiqiza nokuthengisa imikhiqizo yayo kanye / noma izindleko zokuhlinzeka ngezinsizakalo zayo.
|
-33 936 000 $ |
-44 268 000 $ |
-35 782 000 $ |
-23 711 000 $ |
-24 381 000 $ |
-21 741 000 $ |
-18 388 000 $ |
-17 410 000 $ |
-22 378 000 $ |
-15 910 000 $ |
|
Inani lentengo
Izindleko yizindleko eziphelele zokukhiqizwa nokusatshalaliswa kwemikhiqizo namasevisi yenkampani.
|
34 880 000 $ |
47 460 000 $ |
37 183 000 $ |
26 784 000 $ |
32 279 000 $ |
29 554 000 $ |
26 114 000 $ |
25 309 000 $ |
27 144 000 $ |
23 429 000 $ |
|
Ingqikithi yenzuzo
Imali engenayo ibalwa ngokuphindaphinda ubuningi bezimpahla ezithengiswa ngentengo yezimpahla.
|
944 000 $ |
3 192 000 $ |
1 401 000 $ |
3 073 000 $ |
7 898 000 $ |
7 813 000 $ |
7 726 000 $ |
7 899 000 $ |
4 766 000 $ |
7 519 000 $ |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyinzuzo evela ebhizinisini lenhloko yenkampani. Isibonelo, umthengisi udala imali engenayo ngokusebenzisa ukudayiswa kwezimpahla, kanti udokotela uthola inzuzo emisebenzini yezokwelapha ayinikezayo.
|
- |
- |
- |
- |
7 898 000 $ |
7 813 000 $ |
7 726 000 $ |
7 899 000 $ |
4 766 000 $ |
7 519 000 $ |
|
Imali engenayo yokusebenza
Imali engenayo yokusebenza iyisilinganiso sokuphendula esilinganisa inani lemali etholakalayo emisebenzini yebhizinisi, ngemuva kokunciphisa izindleko zokusebenza, njengeholo, ukwehla kwenani kanye nezindleko zezimpahla ezithengiswayo.
|
-54 914 000 $ |
-63 980 000 $ |
-54 385 000 $ |
-40 595 000 $ |
-38 578 000 $ |
-33 659 000 $ |
-28 552 000 $ |
-24 923 000 $ |
-29 560 000 $ |
-26 652 000 $ |
|
Imali engenayo
Imali engenayo iyinzuzo yebhizinisi ngaphandle kwezindleko zezimpahla ezithengisiwe, izindleko nezintela esikhathini sokubika.
|
-67 455 000 $ |
-65 776 000 $ |
-65 456 000 $ |
-67 581 000 $ |
-39 694 000 $ |
-34 380 000 $ |
-29 154 000 $ |
-25 583 000 $ |
-30 835 000 $ |
-28 211 000 $ |
|
Izindleko ze-R & D
Izindleko zokucwaninga nezentuthuko - izindleko zocwaningo zokuthuthukisa imikhiqizo nezinqubo ezikhona noma ukuthuthukisa imikhiqizo nezinqubo ezintsha.
|
- |
- |
- |
- |
- |
- |
- |
97 288 000 $ |
97 288 000 $ |
97 288 000 $ |
|
Izindleko zokusebenza
Izindleko zokusebenza yizindleko ibhizinisi elizibandakanya ngenxa yokwenza imisebenzi yalo evamile yebhizinisi.
|
55 858 000 $ |
67 172 000 $ |
55 786 000 $ |
43 668 000 $ |
46 476 000 $ |
41 472 000 $ |
36 278 000 $ |
32 822 000 $ |
34 326 000 $ |
34 171 000 $ |
|
Amafa wamanje
Izimpahla zamanje ziyingxenye yebhalansi emela ukubaluleka kwazo zonke izimpahla ezingashintshwa zibe yikheshi phakathi nonyaka owodwa.
|
805 520 000 $ |
847 338 000 $ |
607 032 000 $ |
640 467 000 $ |
246 531 000 $ |
287 211 000 $ |
317 472 000 $ |
342 273 000 $ |
379 818 000 $ |
172 412 000 $ |
|
Inani lempahla
Ingqikithi yempahla iyinani elilingana nengqikithi yenani eliphelele lenhlangano, amanothi esikweletu, nempahla ebonakalayo.
|
815 084 000 $ |
857 598 000 $ |
612 997 000 $ |
652 404 000 $ |
259 123 000 $ |
300 488 000 $ |
331 285 000 $ |
345 208 000 $ |
382 109 000 $ |
174 719 000 $ |
|
Imali yamanje
Imali yamanje yimali yonke imali egcinwe yinkampani ngosuku lombiko.
|
777 624 000 $ |
818 150 000 $ |
578 263 000 $ |
610 419 000 $ |
240 149 000 $ |
280 449 000 $ |
313 056 000 $ |
337 790 000 $ |
375 185 000 $ |
138 676 000 $ |
|
Isikweletu samanje
Isikweletu samanje siyingxenye yesikweletu esikhokhwa phakathi nonyaka (izinyanga ezingu-12) futhi siboniswa njengesibophezelo samanje kanye nengxenye yenani elisebenzayo.
|
- |
- |
- |
- |
74 562 000 $ |
67 709 000 $ |
61 205 000 $ |
55 920 000 $ |
62 867 000 $ |
55 734 000 $ |
|
Inani lemali
Ingqikithi yenkokhelo yinani lazo zonke imali enkampani enayo kuma-akhawunti ayo, kufaka phakathi imali encane nemali ebanjwe ebhange.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Isikweletu sonke
Ingqikithi yesikweletu iyinhlanganisela yesikweletu sesikhashana nesikhathi eside. Izikweleti zesikhashana esifushane yizo okufanele zibuyiselwe phakathi nonyaka. Isikweletu sesikhathi eside sihlanganisa zonke izikweletu okufanele zibuyiselwe ngemuva konyaka owodwa.
|
- |
- |
- |
- |
326 546 000 $ |
333 961 000 $ |
335 895 000 $ |
330 049 000 $ |
344 564 000 $ |
342 593 000 $ |
|
Isikweletu sesilinganiso
Ingqikithi yesamba semali ephelele yezimpahla yi-ratio yezezimali ekhombisa iphesenti yezimpahla zenkampani ezimele njengesikweletu.
|
- |
- |
- |
- |
126.02 % |
111.14 % |
101.39 % |
95.61 % |
90.17 % |
196.08 % |
|
Ukulingana
Ukulingana yinani lazo zonke izimpahla zomnikazi ngemuva kokukhipha izikweletu eziphelele kumpahla ephelele.
|
369 333 000 $ |
417 431 000 $ |
185 844 000 $ |
231 627 000 $ |
-67 423 000 $ |
-33 473 000 $ |
-4 610 000 $ |
15 159 000 $ |
37 545 000 $ |
-167 874 000 $ |
|
Ukugeleza kwemali
Ukugeleza kwezimali kuyinani eliphelele lemali kanye nezilinganiso zemali ezihamba enhlanganweni.
|
- |
- |
- |
- |
-40 335 000 $ |
-32 709 000 $ |
-28 732 000 $ |
-37 497 000 $ |
3 142 000 $ |
-25 407 000 $ |
|
|
Umbiko wamuva wezezimali ngemali engenayo Reata Pharmaceuticals, Inc. kwakungu-31/03/2021. Ngokombiko wamuva ngemiphumela yezezimali ye-Reata Pharmaceuticals, Inc., imali engenayo ye-Reata Pharmaceuticals, Inc. yayingu-944 000 US dollar futhi ishintshwe yaba ngu--87.782% uma kuqhathaniswa nonyaka odlule. Inzuzo enenetha ye Reata Pharmaceuticals, Inc. engxenyeni yokugcina yayingu--67 455 000 $, inzuzo enenzuzo ishintshwe ngu-0% uma kuqhathaniswa nonyaka odlule.
|
